esophageal varices: Abnormally dilated veins of the esophagus.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1457 |
4. Check minimum number of eventsNone |
1457 |
5. Include endpointsNone |
1457 |
6. Filter based on genotype QC (FinnGen only) |
1457 |
Control definitions (FinnGen only)
- Control exclude
- I9_DISVEINLYMPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I80-I89
- Name in latin
- Varices oesophagi
Similar endpoints
↥List of similar endpoints to
Oesophageal varices
based on the number of shared cases.
Similar with more cases:
- Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15571 | 4582 | 10653 |
| Only index persons | 9567 | 3029 | 6538 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.13 | 0.30 |
| Only index persons | 0.21 | 0.11 | 0.25 |
| Median age at first event (years) | |||
| Whole population | 59.23 | 62.25 | 57.96 |
| Only index persons | 60.61 | 62.62 | 59.68 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1457 | 509 | 948 |
| Unadjusted period prevalence (%) | 0.33 | 0.17 | 0.42 |
| Median age at first event (years) | 62.47 | 62.87 | 62.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1292
- Matched controls
- 12920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
171.8
323.0
492
46
C03DA01
ATC
spironolactone; oral
21.6
323.0
727
726
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4503599627370496.0
323.0
1079
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
23.5
323.0
1082
2320
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
+∞
323.0
403
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
752.5
323.0
337
6
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
129.6
323.0
544
72
R18
ICD-10 Finland
Ascites
59.5
288.0
337
76
C07AA05
ATC
propranolol; systemic
9.8
262.8
646
1191
K92.0
ICD-10 Finland
Haematemesis
33.7
240.9
320
125
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
11.4
215.2
447
570
C03CA01
ATC
furosemide; systemic
6.5
205.8
779
2458
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.1
191.2
507
955
K92.1
ICD-10 Finland
Melaena
13.4
172.3
320
309
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
34.1
172.2
227
80
A06AD11
ATC
lactulose; oral
6.9
168.0
505
1104
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
23.2
142.8
210
107
Z94.4
ICD-10 Finland
Liver transplant status
128.9
120.4
128
11
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
55.4
117.1
139
28
D64.9
ICD-10 Finland
Anaemia, unspecified
6.3
113.2
343
704
JJC00
NOMESCO Finland
Allogenic transplantation of liver
247.1
111.6
113
5
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
21.0
109.7
166
90
K70.4
ICD-10 Finland
Alcoholic hepatic failure
78.9
108.5
122
17
C07AG02
ATC
carvedilol; oral
7.5
98.8
253
405
I81
ICD-10 Finland
Portal vein thrombosis
+∞
97.1
92
*
A07AA11
ATC
rifaximin; oral
261.7
96.0
97
*
127
Kela drug reimbursment
Transplant complication
20.6
87.0
132
71
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.9
85.9
112
35
K70.1
ICD-10 Finland
Alcoholic hepatitis
40.5
85.7
108
29
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
6.7
85.4
236
415
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
6.1
80.0
237
455
UJF32
NOMESCO Finland
Coloscopy
3.4
79.5
518
2129
A05AA02
ATC
ursodeoxycholic acid; oral
23.0
78.1
114
54
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
72.4
77.4
88
13
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
10.7
77.3
156
164
A02BC02
ATC
pantoprazole; systemic
3.2
75.1
981
6417
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.3
74.7
500
2076
L04AA06
ATC
mycophenolic acid; systemic
18.1
73.2
116
70
K72.1
ICD-10 Finland
Chronic hepatic failure
156.7
70.7
74
5
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
156.7
70.7
74
5
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
69.9
546
2496
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
354.9
68.2
68
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.4
67.7
221
471
A10AE04
ATC
insulin glargine; parenteral
4.7
66.9
257
654
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
52.4
66.1
79
16
N02AX02
ATC
tramadol; systemic, rectal
2.7
64.6
707
3941
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.2
61.5
120
117
WW500
NOMESCO Finland
Blood transfusion
7.7
61.3
150
217
D97
ICPC
Liver disease NOS
41.2
59.2
74
19
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.3
58.7
105
85
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
9.5
58.3
124
142
K72.9
ICD-10 Finland
Hepatic failure, unspecified
51.1
56.7
68
14
UJD02
NOMESCO Finland
Gastroscopy
6.2
56.1
160
286
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
55.4
394
1636
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
54.4
340
1289
L04AD01
ATC
ciclosporin; systemic
11.6
52.9
101
94
45499
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
+∞
52.4
50
*
JJ5AT
NOMESCO Finland
NA
143.4
52.2
55
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.8
51.9
248
759
K83.0
ICD-10 Finland
Cholangitis
15.0
51.4
87
62
K76.7
ICD-10 Finland
Hepatorenal syndrome
114.7
51.2
55
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
49.6
702
4266
K76.9
ICD-10 Finland
Liver disease, unspecified
14.9
49.0
83
59
K70.0
ICD-10 Finland
Alcoholic fatty liver
23.8
48.8
70
31
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
48.7
187
466
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
9.4
48.3
103
118
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.6
48.1
456
2227
K29.6
ICD-10 Finland
Other gastritis
15.9
47.3
78
52
JCA20
NOMESCO Finland
Ligature of oesophageal varices
+∞
47.2
45
*
I86.4
ICD-10 Finland
Gastric varices
+∞
46.1
44
*
A10BA02
ATC
metformin; oral
2.5
45.8
496
2587
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
23.1
45.7
66
30
K76.6
ICD-10 Finland
Portal hypertension
463.0
45.5
45
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.3
45.2
126
217
4560A
ICD-9 Finland
Varicose veins of other sites, Oesophageal varices with bleeding
+∞
45.0
43
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
41.7
45.0
56
14
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
29.9
44.7
60
21
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.8
44.5
106
146
WX002
NOMESCO Finland
Sedation and analgesia
2.7
43.1
351
1548
T90
ICPC
Diabetes non-insulin dependent
2.5
42.9
427
2113
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
16.0
42.7
70
46
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.0
40.8
76
67
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
40.7
297
1219
P15
ICPC
Chronic alcohol abuse
7.2
39.8
100
149
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.9
39.5
178
511
B18.2
ICD-10 Finland
Chronic viral hepatitis C
20.5
39.5
59
30
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.1
38.9
79
83
PHD99
NOMESCO Finland
Resection of other vein
+∞
38.7
37
*
TK800
NOMESCO Finland
Hemodialysis
7.8
38.7
92
126
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
38.5
178
522
Z2446
NOMESCO Finland
Social worker
4.3
38.4
151
382
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
36.3
38.3
49
14
F10.20
ICD-10 Finland
Alcohol dependence currently independent
8.6
37.9
84
103
WX892
NOMESCO Finland
Monitored bed care
3.8
37.7
176
520
I85
ICD-10 Finland
Oesophageal varices
+∞
37.7
36
*
J01MA02
ATC
ciprofloxacin; systemic
2.2
37.7
589
3581
ZX120
NOMESCO Finland
Intravenous
3.4
36.5
193
630
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
15.4
35.6
59
40
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
35.2
215
778
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
34.7
205
725
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
9.4
34.6
73
82
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.7
33.5
74
90
K29.7
ICD-10 Finland
Gastritis, unspecified
5.5
33.5
104
204
A10BH01
ATC
sitagliptin; oral
3.1
33.4
205
740
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
119.7
32.8
35
*
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
119.7
32.8
35
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.7
32.3
153
455
PHD76
NOMESCO Finland
Resection of long saphenous vein
+∞
31.4
30
*
JN4CD
NOMESCO Finland
Very extensive body CT
4.5
31.2
116
277
Z2221
NOMESCO Finland
Medical doctor
2.2
31.0
394
2133
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
10.1
30.8
62
64
TKC20
NOMESCO Finland
Catheterisation of bladder
3.5
30.7
152
468
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
16.4
30.4
49
31
R4110
NOMESCO Finland
Physiotherapy
2.2
30.2
407
2259
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
29.5
196
744
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
29.3
282
1330
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
28.5
453
2683
A10AE05
ATC
insulin detemir; parenteral
4.0
28.3
120
324
ZXD05
NOMESCO Finland
Urgent procedure
2.1
28.3
439
2574
4549X
ICD-9 Finland
Varicose veins of lower extremities, Without mention of ulcer or inflammation
+∞
28.2
27
*
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
5.7
28.2
83
153
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
18.5
28.0
43
24
L04AX01
ATC
azathioprine; systemic
5.1
27.9
91
189
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
79.4
27.9
31
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
27.7
114
299
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
27.5
194
764
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
27.2
168
606
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
5.7
27.2
80
147
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
6.2
27.2
75
127
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
27.1
426
2500
A10BB12
ATC
glimepiride; oral
3.2
27.0
153
521
UJF30
NOMESCO Finland
Ileoscopy through colon
3.0
27.0
166
597
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
26.8
264
1254
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
26.7
71
115
Z51.5
ICD-10 Finland
Palliative care
3.6
26.4
124
365
R50.9
ICD-10 Finland
Fever, unspecified
2.5
26.1
226
1001
K74.0
ICD-10 Finland
Hepatic fibrosis
61.3
26.0
30
5
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
31.7
26.0
34
11
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
15.4
25.6
42
28
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
36.4
25.3
32
9
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
254.6
24.7
25
*
F10.24
ICD-10 Finland
Alcohol depence active use
7.9
24.7
57
75
JN4BD
NOMESCO Finland
Extensive body CT
2.6
24.7
199
845
H02AB04
ATC
methylprednisolone; systemic
2.4
24.4
228
1049
N07BB01
ATC
disulfiram; oral
4.0
24.3
102
273
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
23.2
24.0
34
15
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.3
23.6
91
225
N05BA04
ATC
oxazepam; oral
2.1
23.4
329
1823
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
23.3
262
1317
AA1AD
NOMESCO Finland
CT of head and brain
2.0
23.0
351
2010
5611
FHL
Vena saphena Magna and / or swarm of nodule and possible local emissions
+∞
23.0
22
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.4
23.0
85
202
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
40.8
22.7
28
7
JDA22
NOMESCO Finland
Endoscopic ligature of varices of stomach
233.8
22.7
23
*
XW000
NOMESCO Finland
Bone marrow biopsy
4.1
22.6
92
239
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.5
22.4
67
126
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.9
22.3
96
263
G93.4
ICD-10 Finland
Encephalopathy, unspecified
35.7
22.1
28
8
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
3.5
21.9
108
331
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
20.5
21.7
32
16
5712A
ICD-9 Finland
Chronic liver disease and cirrhosis, Alcoholic cirrhosis of liver
116.9
21.6
23
*
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
6.5
21.4
56
89
SPAT1262
SPAT
Handing over of treatment supplies
2.1
21.2
295
1620
198
Kela drug reimbursment
Sorafenib
34.4
21.2
27
8
J01MA12
ATC
levofloxacin; systemic
2.1
21.1
281
1515
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.4
21.0
108
341
K65.0
ICD-10 Finland
Acute peritonitis
9.2
20.7
43
48
N05CF01
ATC
zopiclone; oral
1.8
20.5
435
2790
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.3
20.5
106
337
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
8.5
20.2
44
53
ZXE00
NOMESCO Finland
One hour or less
1.8
20.2
501
3378
N06AX11
ATC
mirtazapine; oral
1.9
20.1
397
2477
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.4
20.0
99
304
A46
ICD-10 Finland
Erysipelas
2.3
19.9
202
962
1324
FHL
Esophagoscopy and sclerotherapy
+∞
19.8
19
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
19.8
161
683
A28
ICPC
Limited function/disability NOS
2.3
19.7
212
1035
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
74.6
19.7
22
*
WX882
NOMESCO Finland
High dependency care
4.4
19.6
73
175
Z3231
NOMESCO Finland
Registered nurse
1.9
19.4
383
2386
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.5
19.4
93
279
K83.1
ICD-10 Finland
Obstruction of bile duct
7.6
19.3
45
61
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
12.4
19.1
34
28
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
19.1
212
1051
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.3
18.6
71
174
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.0
18.5
60
125
JN4AD
NOMESCO Finland
Body CT examination
2.7
18.3
136
546
SPAT1255
SPAT
Intravenous administration of medicine
3.0
18.2
111
396
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.6
18.2
85
250
N02AA05
ATC
oxycodone; systemic
2.1
18.0
215
1097
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
15.6
18.0
29
19
TJA10
NOMESCO Finland
Laparocentesis
33.4
18.0
23
7
B01AB05
ATC
enoxaparin; parenteral
1.8
18.0
377
2387
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
16.8
17.9
28
17
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
17.8
120
457
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
10.5
17.7
34
33
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
37.2
17.6
22
6
A02BC01
ATC
omeprazole; systemic
1.8
17.6
368
2322
D73.1
ICD-10 Finland
Hypersplenism
96.3
17.6
19
*
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
182.2
17.5
18
*
R41.0
ICD-10 Finland
Disorientation, unspecified
4.3
17.5
65
156
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.5
17.5
85
258
M04AA01
ATC
allopurinol; systemic
2.1
17.1
211
1091
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.3
16.9
52
102
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
16.7
204
1050
D25
ICPC
Abdominal distension
7.2
16.7
40
57
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
6.6
16.5
42
65
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
10.2
16.5
32
32
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
10.2
16.5
32
32
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
9.6
16.4
33
35
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
23.4
16.4
23
10
A41.8
ICD-10 Finland
Other specified sepsis
6.2
16.4
44
73
A10BH05
ATC
linagliptin; oral
3.2
16.4
88
288
Z3226
NOMESCO Finland
Physiotherapist
2.0
16.4
252
1422
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
16.3
69
187
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
8.5
16.3
35
42
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
16.2
144
637
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
16.1
360
2309
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
30.4
16.1
21
7
C10AC01
ATC
colestyramine; oral
4.5
16.1
57
131
K86.1
ICD-10 Finland
Other chronic pancreatitis
9.1
16.0
33
37
WX872
NOMESCO Finland
Intensive care
2.9
15.8
99
358
L01XE05
ATC
[U] sorafenib; oral
33.8
15.7
20
6
UJF92
NOMESCO Finland
Capsular endoscopy
5.2
15.7
49
98
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
+∞
15.6
15
*
JCA35
NOMESCO Finland
Endoscopic contact coagulation in oesophagus
+∞
15.6
15
*
3AC01
NOMESCO Finland
NA
8.6
15.5
33
39
UJC12
NOMESCO Finland
Flexible oesophagoscopy
10.2
15.5
30
30
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.7
15.4
68
191
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
38.5
15.4
19
5
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.9
15.2
96
348
K29.2
ICD-10 Finland
Alcoholic gastritis
18.0
15.2
23
13
R60.0
ICD-10 Finland
Localized oedema
2.3
15.1
145
669
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.3
15.1
56
135
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
14.1
15.0
25
18
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
7.7
14.9
34
45
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
32.1
14.8
19
6
B82
ICPC
Anaemia other/unspecified
4.5
14.8
52
119
E87.6
ICD-10 Finland
Hypokalaemia
3.9
14.7
61
163
R53
ICD-10 Finland
Malaise and fatigue
1.9
14.7
246
1429
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
21.3
14.7
21
10
4561A
ICD-9 Finland
Varicose veins of other sites, Oesophageal varices without mention of bleeding
+∞
14.6
14
*
P16
ICPC
Acute alcohol abuse
6.1
14.6
39
65
160
Kela drug reimbursment
exenatide
4.7
14.6
49
107
A98
ICPC
Health maint/preventive medicine
0.6
14.6
993
11050
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.6
14.5
112
462
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
4.3
14.5
53
126
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.3
14.3
72
225
K65.8
ICD-10 Finland
Other peritonitis
27.5
14.3
19
7
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
8.7
14.3
30
35
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.8
14.2
47
101
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.0
14.2
82
283
N05CD07
ATC
temazepam; oral
2.1
14.2
182
953
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
14.1
91
337
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.7
14.1
378
2546
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
7.3
14.0
33
46
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
6.5
14.0
36
57
UJK02
NOMESCO Finland
ERCP
3.9
14.0
57
150
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.8
13.9
58
156
SPAT1088
SPAT
Blood transfusion
10.6
13.7
26
25
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
7.7
13.7
31
41
R04.0
ICD-10 Finland
Epistaxis
2.5
13.6
111
470
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
13.5
96
377
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.3
13.5
41
80
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.2
13.5
70
224
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
13.5
78
269
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
13.3
397
2745
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
13.2
245
1470
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.2
13.1
50
124
A41.9
ICD-10 Finland
Sepsis, unspecified
3.2
13.0
68
219
RS220
NOMESCO Finland
NA
6.8
13.0
32
48
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.7
13.0
43
93
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
22.8
12.9
18
8
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
6.7
12.8
32
49
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
5.1
12.8
40
81
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
7.3
12.8
30
42
E87.5
ICD-10 Finland
Hyperkalaemia
5.5
12.7
37
69
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.6
12.7
29
39
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
7.1
12.6
30
43
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.1
12.5
39
79
5716A
ICD-9 Finland
Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]
131.1
12.4
13
*
L28
ICPC
Limited function/disability (L)
1.9
12.4
191
1071
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.6
12.3
89
354
SPAT1265
SPAT
Breathalyser
7.2
12.3
29
41
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
12.3
243
1486
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.5
12.2
43
99
K85
ICD-10 Finland
Acute pancreatitis
4.7
12.2
41
90
D64.8
ICD-10 Finland
Other specified anaemias
5.0
12.2
38
77
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.1
12.1
141
708
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
12.0
40
87
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
11.2
12.0
22
20
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
4.6
12.0
41
92
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.9
475
3514
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
47.1
11.9
14
*
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
11.8
11.8
21
18
Z72.1
ICD-10 Finland
Alcohol use
5.7
11.8
33
59
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
11.8
94
393
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
10.6
11.8
22
21
N05AH04
ATC
quetiapine; oral
1.9
11.7
175
971
A02BC03
ATC
lansoprazole; oral
1.6
11.7
347
2382
A10BB01
ATC
glibenclamide; oral
2.9
11.6
69
244
I86.8
ICD-10 Finland
Varicose veins of other specified sites
65.5
11.6
13
*
A10BG03
ATC
pioglitazone; oral
3.6
11.4
50
141
K74.2
ICD-10 Finland
Hepatic fibrosis with hepatic sclerosis
120.9
11.4
12
*
B80
ICPC
Iron deficiency anaemia
4.7
11.4
38
83
SPAT1254
SPAT
Administration of medicine
1.9
11.4
178
1004
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.6
11.4
50
142
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.8
11.2
47
128
K29.1
ICD-10 Finland
Other acute gastritis
5.5
11.2
32
59
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.6
11.2
81
323
K75.4
ICD-10 Finland
Autoimmune hepatitis
25.2
11.1
15
6
K76.89
ICD-10 Finland
Other specified diseases of liver
20.2
11.1
16
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
11.1
451
3336
D50.8
ICD-10 Finland
Other iron deficiency anaemias
6.5
11.1
28
44
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.2
11.1
41
100
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
7.1
11.1
26
37
WVA20
NOMESCO Finland
Medicine administration
4.1
11.0
42
105
JAH00
NOMESCO Finland
Laparotomy
3.4
11.0
52
157
M10.9
ICD-10 Finland
Gout, unspecified
2.3
11.0
105
482
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.2
10.9
33
65
K22.1
ICD-10 Finland
Ulcer of oesophagus
3.8
10.9
45
121
A10BJ02
ATC
liraglutide; parenteral
3.9
10.8
43
112
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
9.7
10.8
21
22
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.7
249
1593
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
10.7
176
1007
K51.5
ICD-10 Finland
Left sided colitis
4.0
10.6
41
104
RS122
NOMESCO Finland
NA
60.5
10.6
12
*
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
6.1
10.6
28
47
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
10.6
428
3153
J01FF01
ATC
clindamycin; systemic
1.6
10.6
320
2199
A12BA01
ATC
potassium chloride; oral
2.8
10.5
67
248
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
10.1
10.5
20
20
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
14.3
10.5
17
12
UJD10
SPAT
NA
5.7
10.4
29
52
I98.2
ICD-10 Finland
Oesophageal varices without bleeding in diseases classified elsewhere
+∞
10.4
10
*
A02BA03
ATC
famotidine; systemic
2.8
10.4
66
244
J94.8
ICD-10 Finland
Other specified pleural conditions
4.6
10.4
35
78
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.9
10.4
25
37
3A422
NOMESCO Finland
NA
32.8
10.3
13
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
10.3
79
325
K70
ICD-10 Finland
Alcoholic liver disease
23.5
10.2
14
6
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
6.3
10.2
26
42
K86.3
ICD-10 Finland
Pseudocyst of pancreas
8.5
10.1
21
25
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.2
10.0
30
59
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
6.1
10.0
26
43
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.9
10.0
60
215
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
10.0
134
715
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.2
9.9
36
87
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
16.8
9.9
15
9
H26.3
ICD-10 Finland
Drug-induced cataract
12.3
9.9
17
14
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
9.8
88
393
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
26.2
9.8
13
5
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
26.2
9.8
13
5
XX4BW
NOMESCO Finland
NA
20.2
9.8
14
7
L04AA01
ATC
[U] ciclosporin; systemic
4.5
9.8
33
74
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
9.8
58
206
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
9.8
134
720
ZXD35
NOMESCO Finland
Usual procedure
3.1
9.7
51
167
A10BD07
ATC
metformin and sitagliptin; systemic
2.5
9.7
78
328
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
3.7
9.7
41
114
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
55.4
9.7
11
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
9.6
287
1960
N06AX16
ATC
venlafaxine; oral
1.9
9.6
142
783
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.4
9.6
24
38
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
10.1
9.5
18
18
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
9.5
64
245
UJK12
NOMESCO Finland
Peroral cholangioscopy
15.1
9.5
15
10
N19
ICD-10 Finland
Unspecified kidney failure
2.9
9.4
56
200
I82.0
ICD-10 Finland
Budd-Chiari syndrome
+∞
9.4
9
*
N06AB04
ATC
citalopram; systemic
1.6
9.4
243
1598
JAF10
NOMESCO Finland
Repair of umbilical hernia
3.4
9.4
44
133
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
21.8
9.4
13
6
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
9.3
84
376
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
8.7
9.3
19
22
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
9.6
9.3
18
19
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
9.6
9.3
18
19
A10BX04
ATC
[U] exenatide; parenteral
5.1
9.3
28
56
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.9
9.3
36
93
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.9
9.2
54
190
R40.2
ICD-10 Finland
Coma, unspecified
7.3
9.2
21
29
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
5.8
9.2
25
44
C10AA07
ATC
rosuvastatin; oral
0.6
9.2
144
2278
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
9.2
172
1026
WX402
NOMESCO Finland
General anaesthesia
1.7
9.2
201
1262
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
9.2
93
439
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.3
9.1
32
75
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.7
9.0
14
9
ZX108
NOMESCO Finland
Inhalation
7.1
9.0
21
30
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
9.0
150
2340
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
9.0
68
278
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
9.0
132
728
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
9.0
402
3010
RS120
NOMESCO Finland
NA
18.7
8.9
13
7
JJA20
NOMESCO Finland
Open biopsy of liver
18.7
8.9
13
7
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.2
8.9
45
144
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
12.6
8.9
15
12
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
12.6
8.9
15
12
N05BA01
ATC
diazepam; systemic, rectal
1.8
8.8
159
939
ZXA00
NOMESCO Finland
Right side
1.5
8.8
317
2258
D45
ICD-10 Finland
Polycythaemia vera
6.4
8.8
22
35
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
3.7
8.8
37
103
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.7
8.8
36
98
A10AE06
ATC
insulin degludec; parenteral
3.2
8.8
45
146
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
8.7
69
290
E000001
ATC
NA
1.7
8.7
213
1378
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4.1
8.7
32
79
R4190
NOMESCO Finland
Nutritional therapy
2.9
8.7
51
181
R11
ICD-10 Finland
Nausea and vomiting
2.2
8.7
85
397
V03AE01
ATC
polystyrene sulfonate; oral
5.1
8.7
26
52
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.3
8.6
80
364
A10BX07
ATC
[U] liraglutide; parenteral
4.8
8.6
27
57
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.4
8.6
40
121
D69.5
ICD-10 Finland
Secondary thrombocytopenia
16.4
8.6
13
8
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.0
8.5
107
556
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
8.5
151
884
K26.4
ICD-10 Finland
Duodenal ulcer, chronic or unspecified with haemorrhage
9.0
8.5
17
19
205
Kela drug reimbursment
Chronic hypertension
1.5
8.5
361
2661
OAB43
SPAT
NA
0.4
8.5
27
724
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
27.7
8.5
11
*
S97
ICPC
Chronic ulcer skin
2.4
8.5
71
308
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
5.7
8.4
23
41
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.4
93
1614
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
4.7
8.4
27
58
E0000UV
ATC
NA
1.5
8.4
409
3104
P01AB01
ATC
metronidazole; oral, rectal
1.5
8.4
398
3006
Z94.0
ICD-10 Finland
Kidney transplant status
4.9
8.4
26
54
WX730
NOMESCO Finland
Conventional respirator
4.0
8.4
32
82
Q44.29
ICD-10 Finland
Atresia of bile ducts
+∞
8.3
8
*
PH3YT
NOMESCO Finland
Insertion of catheter from portal vein to liver vein (TIPS)
+∞
8.3
8
*
TJC00
NOMESCO Finland
Insertion of ballon tube for tamponade of oesophageal varices
+∞
8.3
8
*
4520A
ICD-9 Finland
Portal vein thrombosis[THROMBOSIS VENAE PORTAE]
+∞
8.3
8
*
R06.0
ICD-10 Finland
Dyspnoea
1.5
8.3
281
1970
WX213
NOMESCO Finland
Lower leg blockade
8.6
8.3
17
20
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
5.6
8.3
23
42
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.8
8.3
15
14
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.3
700
5894
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
14.6
8.2
13
9
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.0
8.1
*
200
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
8.1
119
653
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
8.1
139
807
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
8.1
346
2552
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
11.8
8.1
14
12
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
10.1
8.0
15
15
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
10.1
8.0
15
15
SPAT1247
SPAT
Outpatient detoxication and monitoring
10.1
8.0
15
15
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
22.1
8.0
11
5
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.9
8.0
46
160
N05BA02
ATC
chlordiazepoxide; systemic
3.1
8.0
42
139
K07
ICPC
Swollen ankles/oedema
2.7
8.0
52
197
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
7.9
210
1385
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
13.1
7.9
13
10
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
10.9
7.8
14
13
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
7.8
38
120
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.6
7.7
53
206
A07AA02
ATC
nystatin; oral
2.2
7.7
72
331
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
15.1
7.7
12
8
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
45.2
7.7
9
*
L04AA10
ATC
sirolimus; oral
45.2
7.7
9
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
7.7
25
55
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
5.6
7.7
21
38
H02AB09
ATC
hydrocortisone; systemic
3.3
7.7
36
110
A07EC02
ATC
mesalazine; oral, rectal
2.3
7.7
66
292
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.5
7.6
33
95
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.1
7.6
16
20
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
11.9
7.6
13
11
I78.8
ICD-10 Finland
Other diseases of capillaries
11.9
7.6
13
11
K55.8
ICD-10 Finland
Other vascular disorders of intestine
8.9
7.5
15
17
K26.7
ICD-10 Finland
Duodenal ulcer, chronic without haemorrhage or perforation
8.9
7.5
15
17
N06AB10
ATC
escitalopram; oral
1.6
7.5
185
1197
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
3.1
7.5
38
123
K08.3
ICD-10 Finland
Retained dental root
2.0
7.4
92
475
TJA00
NOMESCO Finland
Puncture of peritoneum
80.5
7.4
8
*
2BB01
NOMESCO Finland
NA
80.5
7.4
8
*
J01DB01
ATC
cefalexin; oral
1.4
7.4
943
8453
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
7.7
7.4
16
21
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.0
7.4
19
32
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
7.3
37
120
E83.1
ICD-10 Finland
Disorders of iron metabolism
10.9
7.3
13
12
W10
ICD-10 Finland
Fall on and from stairs and steps
2.3
7.3
63
278
K76.4
ICD-10 Finland
Peliosis hepatis
+∞
7.3
7
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
+∞
7.3
7
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
+∞
7.3
7
*
K74.4
ICD-10 Finland
Secondary biliary cirrhosis
+∞
7.3
7
*
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
9.4
7.3
14
15
D50
ICD-10 Finland
Iron deficiency anaemia
3.9
7.3
28
73
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.5
7.3
24
54
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.2
7.2
73
348
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
7.3
7.2
16
22
K42.1
ICD-10 Finland
Umbilical hernia with gangrene
30.2
7.1
9
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.2
7.1
25
60
TPH00
NOMESCO Finland
Phlebotomy
8.8
7.0
14
16
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
7.0
171
1104
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
7.0
7.0
16
23
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.5
7.0
52
212
162
Kela drug reimbursment
liraglutide
4.5
7.0
23
52
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.4
7.0
55
232
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
7.0
42
879
D07AC01
ATC
betamethasone; topical
1.4
6.9
378
2911
T89
ICPC
Diabetes insulin dependent
2.6
6.9
48
188
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
7.6
6.9
15
20
B02AA02
ATC
tranexamic acid; systemic
1.8
6.9
125
740
A02BC05
ATC
esomeprazole; systemic
1.4
6.9
451
3589
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
13.8
6.9
11
8
C10AA05
ATC
atorvastatin; oral
0.7
6.9
302
3913
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.3
6.9
32
98
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
6.9
128
762
RS230
NOMESCO Finland
NA
8.3
6.8
14
17
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.5
6.8
29
83
N05CF02
ATC
zolpidem; oral
1.6
6.8
185
1226
K65.9
ICD-10 Finland
Peritonitis, unspecified
11.0
6.8
12
11
A10BK03
ATC
empagliflozin; oral
1.9
6.8
93
499
318
Kela drug reimbursment
Teriparatide
9.4
6.8
13
14
3A064
NOMESCO Finland
NA
9.4
6.8
13
14
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.4
6.8
52
218
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.5
6.8
46
923
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.5
6.7
49
200
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
16.8
6.7
10
6
602
Kela drug reimbursment
Children's severe malnutrition
16.8
6.7
10
6
SPAT1281
SPAT
Other administrative function
2.0
6.7
87
459
D07XC01
ATC
betamethasone, combinations; topical
1.7
6.7
137
842
WX419
NOMESCO Finland
Other general anesthesy
4.7
6.7
21
45
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.1
6.7
69
331
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
6.7
78
394
A08
ICPC
Swelling
2.6
6.7
47
187
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
22.6
6.7
9
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.5
6.7
22
50
N30.0
ICD-10 Finland
Acute cystitis
1.8
6.6
121
718
N05BB01
ATC
hydroxyzine; systemic
2.1
6.6
69
334
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
6.6
53
226
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.9
6.6
17
29
B01AB10
ATC
tinzaparin; parenteral
2.0
6.6
77
389
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
6.6
214
1484
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.6
257
1855
A07EA06
ATC
budesonide; oral, local oral
2.7
6.6
42
157
H05AA02
ATC
teriparatide; parenteral
10.1
6.5
12
12
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
10.1
6.5
12
12
S76
ICPC
Skin infection other
2.3
6.5
58
262
4AA09
NOMESCO Finland
NA
70.1
6.4
7
*
D23
ICPC
Hepatomegaly
70.1
6.4
7
*
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
7.4
6.4
14
19
S01.0
ICD-10 Finland
Open wound of scalp
1.8
6.4
99
556
UJF02
NOMESCO Finland
Peroral enteroscopy
6.6
6.3
15
23
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
6.6
6.3
15
23
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.3
335
2562
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
8.2
6.3
13
16
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.4
6.3
21
547
M01AH05
ATC
etoricoxib; oral
0.7
6.3
461
5536
45600
ICD-8 Finland
Varicose veins of other sites, Of oesophagus
+∞
6.3
6
*
PHM99
NOMESCO Finland
Endovenous obliteration of other vein
+∞
6.3
6
*
PHD77
NOMESCO Finland
Resection of short saphenous vein
+∞
6.3
6
*
TPH10
NOMESCO Finland
Sclerotherapy of varicose veins
+∞
6.3
6
*
PHD78
NOMESCO Finland
Resection of communicating veins of lower leg and thigh
+∞
6.3
6
*
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
+∞
6.3
6
*
45299
ICD-8 Finland
Portal vein thrombosis
+∞
6.3
6
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.8
6.2
19
40
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
7.1
6.2
14
20
N05AB01
ATC
dixyrazine; systemic
3.6
6.2
26
74
A10AB06
ATC
insulin glulisine; parenteral
5.1
6.2
18
36
N18.8
ICD-10 Finland
Other chronic renal failure
2.6
6.2
42
166
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.2
74
378
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
7.7
6.1
13
17
F05.9
ICD-10 Finland
Delirium, unspecified
3.0
6.1
32
108
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
12.6
6.1
10
8
W19
ICD-10 Finland
Unspecified fall
1.8
6.0
107
629
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
10.1
6.0
11
11
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.0
576
4850
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
219
95
26.96
309.64
1.5
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
556
888
9.51
307.65
2.4
2.9
g/l
13.9
10.6
26.18
514
813
(3023487) Leukocytes [#/volume] in Peritoneal fluid
239
35
81.50
307.65
2.8
2.6
e6/l
267.6
873.7
1.77
180
30
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
219
29
88.71
307.65
2.6
2.2
e6/l
1239.3
4455.6
0.96
134
20
(3034770) Mitochondria Ab [Titer] in Serum
512
294
26.32
307.65
1.5
1.2
titre
766.3
2070.0
—
16
8
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
321
155
26.28
307.65
1.3
1.1
g/l
1.6
1.5
1.37
299
142
(3023183) Ammonium ion [Moles/volume] in Plasma
625
269
39.96
307.65
8.1
2.2
umol/l
48.3
36.2
2.69
584
220
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
878
1128
18.09
307.65
6.5
2.1
g/l
0.2
0.2
70.16
802
1058
(3044007) Cell count panel - Peritoneal fluid
190
25
87.26
307.65
2.6
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
588
1085
8.41
307.65
1.7
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
235
77
36.20
307.65
2.6
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
552
160
54.96
307.65
3.9
2.1
u/ml
2204.1
256.8
0.61
545
152
(3026692) Albumin [Mass/volume] in Peritoneal fluid
190
30
72.69
307.65
2.1
1.2
g/l
8.5
14.9
2.86
131
22
(3028026) IgM [Mass/volume] in Serum or Plasma
525
709
11.02
307.65
1.6
1.9
g/l
1.6
1.4
0.80
483
646
(3033799) Differential panel - Peritoneal fluid
205
28
85.05
307.65
2.8
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
702
1343
9.16
307.65
11.8
2.6
umol/l
19.5
8.5
10.50
673
1183
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
610
1148
8.42
307.65
1.7
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
520
291
27.24
307.65
1.5
1.2
titre
87.1
97.8
0.18
65
18
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
695
1662
7.09
303.12
3.4
2.6
%
23.6
23.1
0.22
629
1438
(44816559) Phosphatidylethanol [Mass/volume] in Blood
268
201
16.12
293.48
2.6
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
702
1767
6.74
287.98
3.3
2.5
g/l
2.3
2.3
0.83
647
1652
(3022948) Iron [Moles/volume] in Serum or Plasma
714
1909
6.38
271.97
3.4
2.6
umol/l
12.3
13.1
1.63
675
1779
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
596
1369
6.68
266.50
2.9
1.9
%
1.7
1.5
5.60
510
1189
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
147
35
46.60
248.24
4.9
2.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
526
1172
6.46
240.04
13.4
7.8
mmol/l
10.3
10.2
0.09
511
1119
(3037522) Nuclear Ab [Titer] in Serum
575
1395
6.16
239.39
1.6
1.3
titre
449.4
538.9
0.51
124
283
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
177
94
21.30
229.06
1.1
1.0
mg/l
281.2
285.2
0.14
163
83
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
274
315
10.48
225.66
4.9
2.9
g/l
2.6
3.7
20.47
268
296
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
950
3760
5.39
216.36
13.8
3.2
u/l
51.4
38.4
2.42
922
3564
(4281824)
168
97
19.45
208.93
1.4
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
312
468
8.21
206.55
3.3
3.3
u/ml
121.2
797.8
1.46
274
401
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
166
100
18.61
202.18
1.4
1.1
titre
176.9
149.4
0.10
26
16
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
245
283
10.21
200.28
1.3
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1107
5242
5.64
193.67
18.0
4.9
g/l
31.7
35.3
73.39
1080
4878
(3033658) Prothrombin time (PT) actual/Normal
813
3043
4.79
193.09
20.5
3.9
%
66.3
88.3
89.30
792
2983
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
132
61
23.70
180.50
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
132
61
23.70
180.50
1.2
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
135
66
22.44
180.39
1.2
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
240
309
9.10
179.69
4.0
2.8
%
62.4
90.4
31.23
235
295
(3012095) Magnesium [Moles/volume] in Serum or Plasma
624
2018
4.66
176.54
6.3
3.6
mmol/l
0.8
0.8
18.92
603
1894
(3003458) Phosphate [Moles/volume] in Serum or Plasma
558
1688
4.74
171.40
9.0
6.2
mmol/l
1.1
1.0
0.87
531
1567
(40768797) Stomach Pathology biopsy report
543
1613
4.77
170.62
1.6
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
563
1739
4.65
167.86
3.4
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
763
2964
4.31
166.47
3.8
2.1
mg/l
4.3
2.9
24.42
704
2512
(3026250) Tacrolimus [Mass/volume] in Blood
117
49
25.88
166.02
35.4
32.7
ug/l
7.2
7.4
0.26
102
40
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
238
336
8.27
164.58
2.5
1.7
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
123
60
22.30
164.31
36.8
31.0
ug/l
133.7
132.4
0.04
107
53
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
243
353
8.06
163.92
6.9
5.2
mg/l
1.8
1.6
2.74
233
319
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
180
179
11.33
163.01
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
207
253
9.37
161.02
9.4
5.8
iu/ml
641.9
325.6
0.76
63
41
(3021879) Hepatitis B virus core Ab [Presence] in Serum
336
694
5.99
161.01
1.4
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
213
277
8.84
157.56
4.1
2.9
%
208.9
198.8
0.68
208
265
(3007164) IgA [Mass/volume] in Serum or Plasma
593
2046
4.20
149.71
1.8
1.5
g/l
4.9
2.6
43.98
486
1234
(3032080) INR in Blood by Coagulation assay
1017
5118
4.27
147.62
22.1
8.5
inr
1.3
1.3
1.11
275
1414
(3042733) HLA Ab [Presence] in Serum
106
47
24.25
146.96
1.6
5.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
168
176
10.66
146.37
1.2
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1134
6253
4.68
142.39
26.9
6.3
umol/l
27.3
11.9
35.78
1120
5943
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
438
1256
4.56
140.91
3.7
4.2
ug/l
5.5
25.6
2.11
383
1043
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
470
1435
4.36
138.95
4.1
4.1
u/l
243.3
245.4
0.10
454
1352
(3018677) aPTT in Platelet poor plasma by Coagulation assay
556
1931
4.04
137.21
4.2
2.1
s
32.2
29.8
11.43
541
1874
(3024471) HLA-A [Type]
100
46
23.27
136.53
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
100
46
23.27
136.53
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
227
383
6.84
132.50
3.9
2.4
s
24.3
21.6
7.65
218
345
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
395
1095
4.58
131.96
5.0
2.4
u/l
28.6
40.6
2.19
356
936
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
287
630
5.43
126.90
5.9
5.1
mmol/l
23.0
24.0
5.40
271
573
(3001122) Ferritin [Mass/volume] in Serum or Plasma
913
4563
3.68
126.86
5.1
2.7
ug/l
162.4
160.7
0.04
861
4176
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
174
231
8.42
125.82
1.4
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
81
26
32.93
125.30
3.9
3.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
169
219
8.60
124.66
1.5
1.5
u/ml
119.7
132.3
0.20
23
32
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
168
217
8.62
124.24
1.4
1.3
u/ml
393.7
264.2
2.99
113
124
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
801
3725
3.56
123.95
6.1
2.5
u/l
58.6
58.7
0.01
764
3440
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
174
241
8.06
121.29
1.5
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
453
1472
4.02
120.94
3.2
2.6
%
2.3
1.8
12.68
400
1308
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
122
110
12.01
117.32
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
123
113
11.80
116.84
2.3
2.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
256
576
5.18
109.21
2.0
1.7
g/l
1.0
1.6
20.16
218
491
(3048929) Epstein Barr virus Ab [Presence] in Serum
180
301
6.68
105.25
1.4
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
806
4040
3.23
104.98
10.0
5.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
364
1112
4.03
104.55
13.4
9.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
452
1605
3.63
103.97
18.8
24.5
inr
1.5
1.4
0.84
36
230
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
142
194
8.00
99.76
1.2
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
138
190
7.92
96.25
3.5
3.5
u/ml
1312.3
2683.6
—
7
16
(3044640) Blood type and Crossmatch panel - Blood
747
3729
3.06
95.37
5.5
2.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
444
1639
3.46
95.06
10.9
7.6
mmol/l
105.0
104.3
1.66
438
1599
(46235355) HIV 1 and 2 tests - Meaningful Use set
401
1393
3.59
94.38
1.6
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
371
1246
3.65
91.69
6.4
4.2
kpa
5.4
5.8
15.72
358
1205
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
623
2895
3.01
89.09
5.1
2.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
367
1245
3.60
89.08
6.5
4.2
mmol/l
0.6
1.8
6.83
295
979
(3023368) Bacteria identified in Blood by Culture
697
3462
2.94
87.92
7.1
4.3
—
—
—
0
0
(3012544) pH of Venous blood
373
1292
3.54
87.52
6.4
4.2
—
7.4
—
0
8
(3014111) Lactate [Moles/volume] in Serum or Plasma
346
1143
3.66
87.30
10.7
8.2
mmol/l
2.0
1.4
6.82
330
1093
(3001604) Monocytes [#/volume] in Blood
967
5804
2.98
84.19
10.7
5.8
e9/l
0.6
0.6
3.01
863
4929
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
97
101
10.22
84.19
1.1
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
692
3494
2.87
83.56
7.1
4.1
ph
7.4
7.4
1.68
142
670
(3006315) Basophils [#/volume] in Blood
968
5828
2.97
83.51
10.7
5.8
e9/l
0.0
0.0
6.75
864
4957
(3023520) Reticulocytes [#/volume] in Blood
333
1106
3.61
82.99
3.0
2.7
e9/l
82.4
69.6
6.41
262
849
(3019069) Monocytes/100 leukocytes in Blood
928
5504
2.89
81.59
11.6
6.3
%
10.0
8.9
15.79
893
5124
(3019198) Lymphocytes [#/volume] in Blood
974
5938
2.93
81.04
10.7
5.9
e9/l
1.4
1.9
8.04
884
5146
(3006504) Eosinophils/100 leukocytes in Blood
923
5472
2.88
80.98
11.3
6.0
%
3.1
2.9
1.35
886
5075
(3022096) Basophils/100 leukocytes in Blood
906
5323
2.86
80.82
11.2
6.0
%
0.7
0.7
2.28
869
4946
(3013115) Eosinophils [#/volume] in Blood
981
6009
2.94
80.79
11.2
6.0
e9/l
0.2
0.2
9.73
887
5201
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
922
5480
2.86
80.18
12.9
6.4
mmol/l
1.2
1.2
27.46
873
4946
(3002030) Lymphocytes/100 leukocytes in Blood
934
5613
2.85
79.07
11.3
6.1
%
23.8
27.3
19.98
895
5207
(3018010) Neutrophils/100 leukocytes in Blood
920
5531
2.80
77.02
10.9
5.9
%
59.5
57.4
6.42
883
5158
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
966
5985
2.82
75.69
14.3
7.2
mmol/l
1.2
1.2
20.94
847
5052
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
380
1488
3.10
71.36
11.6
8.0
kpa
4.8
5.1
7.70
366
1420
(3027801) Oxygen [Partial pressure] in Arterial blood
380
1489
3.10
71.27
11.6
8.0
kpa
12.0
12.1
0.17
367
1422
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
236
694
3.86
69.70
13.4
10.9
mmol/l
23.1
24.3
5.00
227
658
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
268
865
3.57
68.88
2.1
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
352
1349
3.12
68.32
11.9
8.4
%
95.9
95.4
0.83
345
1297
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
58
38
15.85
66.84
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
83
96
9.11
66.45
1.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
371
1489
3.00
66.17
11.7
8.0
mmol/l
-0.3
1.0
5.23
306
1158
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
57
37
15.99
66.00
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1095
7594
2.78
62.65
15.4
3.1
u/l
160.0
54.4
59.57
1065
7027
(3013650) Neutrophils [#/volume] in Blood by Automated count
1014
6799
2.62
61.69
14.9
9.0
e9/l
3.6
4.2
11.75
930
5889
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
169
433
4.28
60.02
4.2
2.6
u/ml
0.2
0.3
4.57
101
238
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
874
5520
2.46
59.73
8.3
4.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
320
1251
3.00
59.20
12.8
8.6
g/l
107.4
122.5
24.52
315
1201
(3026782) Osmolality of Urine
492
2404
2.58
59.00
3.5
2.8
mosm/kgh2o
522.2
565.0
3.89
430
2053
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
135
296
4.92
58.23
1.8
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
281
1039
3.11
57.19
1.7
2.7
g/l
64.8
66.6
2.71
261
945
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
143
340
4.56
55.82
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
459
2219
2.56
55.78
1.3
1.3
u/ml
3.2
1.7
0.65
77
570
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
224
733
3.43
55.71
13.1
11.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
600
3298
2.39
54.83
4.3
3.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
465
2283
2.52
54.49
2.1
1.7
nmol/l
1250.1
1158.8
1.12
381
1745
(3030467) Casts [#/volume] in Urine by Automated count
613
3413
2.37
54.26
4.4
3.2
e6/l
1.0
0.4
2.90
500
2594
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
423
2001
2.57
53.48
2.2
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
59
59
10.38
52.48
1.7
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
268
1035
2.95
50.04
5.5
3.7
kpa
5.0
4.6
2.12
255
998
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
119
268
4.75
49.57
2.6
3.3
u/ml
198.4
1407.0
0.69
112
253
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
412
1996
2.48
48.90
3.4
3.0
e6/l
2.6
1.5
1.18
249
1128
(3002582) Erythrocytes [#/volume] in Urine
637
3744
2.25
48.12
4.6
3.3
e6/l
218.6
98.2
0.32
526
2913
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
718
4433
2.22
47.97
4.6
3.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
55
57
9.99
47.67
6.4
2.0
umol/l
40.6
10.5
2.97
47
33
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
423
2124
2.40
45.99
3.3
2.8
e6/l
1.2
1.0
0.56
260
1252
(40758558) Short blood count panel - Blood
527
2929
2.25
44.95
11.5
6.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
88
168
5.51
44.28
2.3
1.6
g/l
0.8
0.9
0.15
67
133
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
767
4972
2.15
44.00
2.6
2.0
pmol/l
93.1
93.6
0.08
421
2633
(3000850) Epithelial cells [#/volume] in Urine
480
2589
2.27
43.82
3.4
2.6
e6/l
5.7
4.7
0.82
435
2287
(4035726)
256
1037
2.78
43.31
1.8
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
513
2864
2.22
42.88
2.0
1.5
nmol/l
18.2
20.5
3.07
458
2439
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
50
54
9.55
42.02
1.9
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
311
1410
2.53
41.83
2.1
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
679
4276
2.10
41.16
5.3
3.7
e6/l
135.1
129.2
0.03
536
3130
(3013826) Glucose [Moles/volume] in Serum or Plasma
994
7223
2.19
41.13
14.4
5.0
mmol/l
7.7
6.9
15.58
966
6806
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
435
2308
2.26
40.85
3.0
1.7
mg/l
3.3
1.2
7.10
381
1788
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
89
186
5.03
40.43
1.2
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
306
1397
2.51
40.43
2.1
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
70
120
6.08
39.40
1.2
1.2
u/l
71.5
51.7
1.41
51
85
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
302
1396
2.47
38.69
2.1
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
548
3278
2.08
37.19
4.9
2.8
umol/l
3054.1
5675.5
0.84
490
2845
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1168
9217
2.35
37.13
29.6
7.4
u/l
125.3
79.9
80.94
1142
8677
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
281
1301
2.44
35.63
4.4
3.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
152
514
3.19
35.25
1.5
1.5
u/ml
4.2
22.3
—
5
12
(3026008) Bacteria identified in Urine by Culture
536
3265
2.02
33.89
3.5
3.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
117
349
3.56
33.10
4.3
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
283
1355
2.35
33.07
2.0
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
686
4586
1.94
32.78
3.9
2.2
nmol/l
70.7
77.0
6.51
634
4071
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
91
235
4.06
31.65
1.8
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
62
122
5.26
30.12
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
55
98
5.79
29.73
1.8
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
100
289
3.64
29.64
2.0
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
183
761
2.61
28.80
1.8
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
742
5245
1.85
28.41
21.9
9.6
e9/l
0.0
0.0
0.11
636
4269
(3000570) Elastase.pancreatic [Mass/mass] in Stool
110
348
3.34
28.35
1.4
1.4
ug/g
270.0
284.3
0.26
74
208
(3020191) Ethanol [Moles/volume] in Serum or Plasma
50
87
5.92
27.69
1.9
1.3
promille
0.7
1.2
1.43
43
64
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
127
445
3.03
27.58
2.5
2.2
ug/l
935.9
568.5
0.26
116
420
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
211
960
2.40
27.35
3.5
2.8
ml/min/173m2
57.1
65.3
1.30
86
369
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
192
837
2.49
27.32
7.1
3.8
mmol/l
0.7
1.8
2.79
141
610
(3012441) Differential panel - Pleural fluid
61
130
4.85
27.05
1.9
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
605
4059
1.84
27.03
4.1
3.2
mmol/l
7.0
7.9
5.90
503
3390
(3019060) Gas panel - Arterial blood
190
836
2.46
26.47
6.1
4.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
256
1286
2.20
26.21
1.5
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
72
180
4.16
26.14
5.2
6.0
mg/l
11.0
11.6
0.36
64
167
(3020682) Albumin/Creatinine [Ratio] in Urine
607
4118
1.81
25.83
4.8
4.0
mg/mmol
14.3
8.3
1.90
409
2686
(3031040) Bacteria [#/volume] in Urine by Automated count
972
7600
1.84
25.50
6.0
4.2
e6/l
423.0
1262.5
—
10
127
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
197
897
2.38
25.40
5.6
4.2
ng/l
98.3
91.8
0.37
179
791
(3009343) pH of Capillary blood
193
872
2.40
25.32
7.2
3.9
ph
7.4
7.4
0.40
28
101
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
193
885
2.36
24.45
7.2
3.9
kpa
4.8
5.1
7.07
184
815
(3003434) Protein [Mass/volume] in Pleural fluid
67
168
4.13
24.23
1.9
1.6
g/l
26.2
32.3
3.10
60
148
(3017181) Myelocytes/100 leukocytes in Blood
206
980
2.28
23.94
6.1
4.1
%
0.9
0.8
0.23
82
296
(3004588) Protein electrophoresis panel - Serum or Plasma
189
869
2.35
23.77
1.6
2.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
191
885
2.33
23.60
6.0
3.9
%
0.7
0.5
1.06
62
213
(3051651) Icteric interference index of Serum or Plasma
44
79
5.71
23.59
3.0
3.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
212
1029
2.24
23.46
2.3
2.2
nmol/l
367.7
369.1
0.02
202
941
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
43
76
5.80
23.44
1.8
1.5
u/l
18.2
8.1
0.60
26
32
(3003181) Sodium [Moles/volume] in Urine
77
219
3.66
23.35
1.4
1.3
mmol/l
49.8
66.6
2.95
52
181
(3012516) Albumin [Mass/volume] in Urine
571
3901
1.76
23.02
3.8
3.3
mg/l
379.5
261.8
0.29
381
2553
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
32
42
7.77
23.00
4.0
2.8
u/ml
8419.7
40003.3
—
7
12
(3045788) Cell count panel - Pleural fluid
54
121
4.60
22.55
1.9
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
86
273
3.29
22.02
1.8
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
61
154
4.09
21.87
2.0
1.5
e6/l
941.0
1731.6
1.69
43
105
(3012501) Base excess in Blood by calculation
87
286
3.17
21.03
6.0
5.3
mmol/l
2.2
2.6
0.53
54
194
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
161
730
2.36
20.82
1.7
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
305
4836
0.53
20.80
2.9
4.2
%
23.0
21.5
0.74
106
2385
(3009871) Measles virus Ab [Titer] in Serum
25
28
9.07
20.34
1.8
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
107
404
2.78
20.23
1.4
3.5
ratio
1.5
1.8
—
9
38
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
538
3727
1.70
19.91
2.5
2.2
u/l
194.4
258.6
1.10
510
3507
(3051611) Lipemic interference index of Serum or Plasma
52
125
4.28
19.89
3.2
3.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
75
233
3.34
19.88
1.5
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
78
249
3.25
19.79
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
78
249
3.25
19.79
1.6
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
47
105
4.59
19.71
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
85
287
3.08
19.64
5.0
4.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
107
411
2.73
19.57
1.5
3.5
mg/l
65.2
69.9
0.11
89
331
(3010421) pH of Blood
93
332
2.92
19.49
6.0
5.0
ph
7.4
7.4
1.13
85
280
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
107
412
2.72
19.48
1.5
3.6
mg/l
53.6
56.8
0.07
89
334
(3003694) ABO and Rh group [Type] in Blood
474
3192
1.72
19.34
1.6
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
52
129
4.14
19.10
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
142
639
2.35
18.64
8.2
4.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
53
137
3.98
18.42
1.8
1.4
e6/l
67439.1
101772.0
0.25
34
80
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
24
8
30.47
18.36
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
87
313
2.89
17.98
1.5
3.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
174
865
2.15
17.95
6.4
4.2
%
1.0
0.1
0.48
66
225
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
33
59
5.70
17.78
1.6
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
33
59
5.70
17.78
1.6
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
125
543
2.42
17.74
2.6
2.0
ug/l
2.8
2.0
0.34
114
480
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
70
5.25
17.74
1.7
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
527
3717
1.65
17.72
3.4
3.0
ng/l
1707.2
1512.2
0.32
467
3184
(36660697) Celiac disease serology panel - Serum
162
787
2.19
17.70
1.2
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
22
6
37.20
17.63
1.2
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
126
551
2.41
17.62
8.2
4.3
mmol/l
23.9
24.8
2.70
120
514
(3037467) Urinalysis macro (dipstick) panel - Urine
974
8007
1.65
17.47
6.1
4.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
107
436
2.57
17.39
2.9
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
379
2459
1.73
17.38
7.4
4.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
49
127
3.96
16.98
1.8
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
179
923
2.07
16.74
6.5
4.2
%
0.1
0.1
1.15
75
267
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
35
70
5.10
16.72
1.7
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
44
107
4.21
16.60
1.3
1.2
nmol/l
1.8
1.5
0.81
39
92
(1761868) Lipid panel - Serum or Plasma
255
4049
0.55
16.42
4.1
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
46
117
4.03
16.36
2.7
2.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
25
38
6.68
15.78
1.9
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
21
9.15
15.57
2.2
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
159
806
2.09
15.53
9.4
6.9
mmol/l
23.4
24.3
1.90
150
743
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
85
327
2.70
15.50
1.5
2.4
g/l
0.0
0.0
0.00
76
297
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
71
248
2.96
15.49
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1037
11693
0.61
15.45
6.2
4.6
mmol/l
4.1
4.6
40.64
961
10769
(3045142) Bone marrow Pathology biopsy report
52
151
3.53
15.33
1.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
80
303
2.74
15.04
2.1
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1067
11928
0.61
14.91
6.4
5.2
mmol/l
2.3
2.7
34.71
980
10936
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
117
533
2.30
14.89
7.8
5.3
%
1.8
1.6
2.00
110
496
(3007930) Methemoglobin/Hemoglobin.total in Blood
116
527
2.31
14.86
7.8
5.3
%
0.8
0.9
0.64
110
490
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
83
323
2.66
14.81
1.5
2.5
g/l
0.0
0.0
0.00
76
296
(3022493) Free Hemoglobin [Mass/volume] in Plasma
28
51
5.58
14.80
1.5
2.9
mg/l
41.8
74.0
2.50
21
39
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1030
11607
0.62
14.80
6.0
4.6
mmol/l
1.3
1.4
21.06
943
10623
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
47
132
3.65
14.57
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
87
350
2.58
14.52
1.5
2.4
g/l
0.0
0.0
0.79
78
320
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
13
11.65
14.43
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
75
281
2.76
14.40
1.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
64
222
2.97
14.15
1.9
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
23
36
6.48
14.12
1.2
1.3
ug/l
13.0
9.3
1.30
23
36
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
82
325
2.61
14.11
2.3
2.3
ug/min
84.1
62.0
0.24
46
193
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
76
290
2.71
14.10
2.1
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
212
3.01
14.06
1.1
1.3
miu/ml
293.8
207.7
0.61
11
80
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
89
368
2.51
14.04
1.5
2.3
g/l
33.9
37.8
6.07
76
316
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
358
2403
1.65
14.04
4.2
3.9
ng/l
307.0
488.4
0.80
296
1974
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
221
3525
0.56
13.97
2.2
3.0
ug/l
0.7
0.8
0.06
148
2341
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
446
5973
0.63
13.82
3.4
4.9
ug/l
1.5
3.0
6.18
376
5382
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
99
441
2.34
13.27
1.6
2.4
g/l
13.5
10.5
4.54
85
375
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
76
300
2.62
13.20
1.4
1.6
g/l
0.2
0.2
2.42
70
284
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
92
399
2.39
13.10
1.6
2.7
g/l
0.5
1.2
1.62
79
348
(3027923) C peptide [Moles/volume] in Serum or Plasma
31
69
4.57
13.10
1.2
1.3
nmol/l
1.3
1.2
0.26
21
55
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
17
6
28.64
12.97
4.3
3.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
173
962
1.91
12.95
6.0
4.0
mmol/l
1.2
1.2
3.53
167
837
(3026361) Erythrocytes [#/volume] in Blood
1205
12997
0.58
12.94
67.9
21.6
e12/l
4.0
4.5
123.47
1176
12594
(3035941) MCH [Entitic mass]
1205
12995
0.58
12.88
67.6
21.5
pg
30.6
30.4
2.01
1188
12796
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
77
310
2.57
12.85
1.4
1.6
g/l
1.0
1.2
2.77
72
294
(3011397) Hemoglobin [Presence] in Urine by Test strip
386
2689
1.59
12.85
4.3
3.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1206
13000
0.58
12.79
67.9
21.6
e9/l
6.2
6.8
9.37
1179
12596
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
109
514
2.21
12.78
1.9
1.9
u/l
52.6
38.3
5.83
94
452
(3018405) Lactate [Moles/volume] in Arterial blood
100
455
2.29
12.77
4.9
3.9
mmol/l
1.9
1.4
2.48
100
446
(3000963) Hemoglobin [Mass/volume] in Blood
1206
12999
0.58
12.75
68.6
21.7
g/l
119.3
136.8
156.08
1190
12797
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
376
2611
1.59
12.66
1.8
1.7
pmol/l
578.6
26275115.3
2.16
310
2177
(3024731) MCV [Entitic volume]
1206
12995
0.58
12.63
67.6
21.5
fl
92.3
91.3
7.53
1190
12797
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
28
59
4.82
12.63
1.7
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
28
59
4.82
12.63
1.7
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1206
12994
0.58
12.60
67.9
21.6
e9/l
161.0
244.2
183.19
1181
12628
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
20
31
6.53
12.38
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
471
2.23
12.17
1.6
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
101
471
2.23
12.17
1.6
2.4
g/l
7.0
7.4
1.25
78
351
(3037121) Protein [Mass/volume] in Urine
97
445
2.26
12.15
2.9
3.6
g/l
0.2
0.3
0.26
66
186
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
59
214
2.83
12.07
4.8
3.8
%
57.7
58.4
0.16
59
214
(3008757) Leukocyte morphology finding [Identifier] in Blood
47
151
3.18
11.87
6.2
4.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1002
8630
1.52
11.80
6.8
4.0
mm/h
23.2
12.5
44.35
949
7957
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
100
471
2.21
11.76
1.6
2.4
g/l
4.4
3.8
2.49
76
337
(3002256) Pathology report gross observation
237
1491
1.70
11.70
1.4
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
43
132
3.33
11.69
1.4
1.2
u/ml
2.1
5.1
1.16
26
63
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
71
289
2.53
11.60
1.2
1.6
nmol/l
0.9
0.8
0.33
55
235
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
43
133
3.30
11.55
1.4
1.2
u/ml
2.5
2.2
0.10
21
49
(3042631) Mycobacterium sp identified in Specimen
51
176
2.97
11.42
2.0
2.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
45
145
3.17
11.32
1.8
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
439
2.22
11.29
1.6
2.4
g/l
3.2
3.1
0.60
78
347
(21494755) Public health laboratory ask at order entry panel
24
875
0.26
11.08
1.5
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
180
1074
1.77
10.69
3.5
3.0
ng/l
205.9
212.8
0.10
164
975
(40768804) Tissue Pathology biopsy report
574
4501
1.45
10.46
2.6
2.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
54
203
2.72
10.36
6.5
3.6
%
1.0
1.4
0.50
47
158
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
80
365
2.26
10.18
1.8
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
28
72
3.95
9.88
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
28
72
3.95
9.88
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
72
3.95
9.88
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
25
6.46
9.82
1.1
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
38
121
3.20
9.78
1.3
1.1
%
82.5
117.4
5.60
33
112
(3015235) Bicarbonate [Moles/volume] in Capillary blood
77
352
2.25
9.76
4.4
3.1
mmol/l
22.5
24.6
3.52
71
302
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
32
5.68
9.76
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
65
277
2.41
9.67
4.6
2.7
%
14.9
16.3
1.65
32
146
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1016
11241
0.68
9.64
5.5
4.1
mmol/l
1.3
1.3
0.22
931
10210
(3015377) Calcium [Moles/volume] in Serum or Plasma
507
3944
1.44
9.39
4.4
3.5
mmol/l
2.3
2.4
12.52
441
3437
(3029075) Extractable nuclear Ab panel - Serum
19
37
5.19
9.37
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
28
75
3.79
9.35
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
28
75
3.79
9.35
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
28
75
3.79
9.35
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
14
20
7.06
9.29
1.5
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
42
147
2.91
9.22
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
74
341
2.23
9.22
1.4
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
34
105
3.29
9.20
2.1
2.2
ml
778.3
632.7
1.24
22
60
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
26
67
3.93
9.16
1.1
1.1
u/l
135.3
78.1
1.43
19
51
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
26
67
3.93
9.16
1.1
1.1
u/l
43.7
28.7
0.63
19
47
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
182
2.69
9.09
1.9
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
28
77
3.69
9.02
1.4
2.4
e6/l
662.8
632.8
—
10
32
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
15
8.06
8.87
1.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
679
5607
1.40
8.77
4.7
3.5
estimate
0.0
0.0
0.00
148
1033
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
125
3.01
8.65
1.2
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
37
127
2.96
8.43
6.9
3.4
%
59.7
54.8
0.51
28
83
(3011412) CD3 cells [#/volume] in Blood
33
106
3.16
8.40
1.4
2.6
e9/l
0.6
1.1
3.97
18
60
(4306422)
36
122
3.00
8.38
1.4
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
35
117
3.04
8.34
1.4
5.4
%
8.8
11.3
2.28
35
117
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
40
145
2.81
8.27
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
40
145
2.81
8.27
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
904
0.37
8.27
1.3
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
38
134
2.89
8.26
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
105
575
1.89
8.23
1.3
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
23
6.14
8.19
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
40
146
2.79
8.17
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
40
146
2.79
8.17
1.5
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
19
42
4.57
8.13
1.6
1.5
%
1.9
1.6
0.16
14
35
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
42
4.57
8.13
1.1
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
17
7.11
8.00
1.7
2.0
%
9.5
5.4
—
6
8
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
583
4756
1.38
7.83
5.4
3.7
ng/l
37.0
54.4
1.11
493
3487
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1061
11543
0.70
7.82
6.3
4.8
mmol/l
6.7
6.1
25.04
980
10456
(3039000) Anion gap in Blood
62
286
2.22
7.74
10.3
7.2
mmol/l
11.8
11.4
0.36
56
253
(3024891) Influenza virus A+B Ag [Presence] in Specimen
62
286
2.22
7.74
1.4
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
62
286
2.22
7.74
10.3
7.2
mmol/l
105.7
105.8
0.06
56
253
(3028271) Lactate [Moles/volume] in Capillary blood
49
204
2.45
7.72
3.3
2.1
mmol/l
1.9
1.7
0.72
49
198
(3020891) Body temperature
94
507
1.91
7.72
7.4
4.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
26
76
3.47
7.69
1.2
2.8
e6/l
356.8
614.6
1.04
21
61
(3024522) Salmonella sp identified in Specimen by Organism specific culture
39
146
2.72
7.61
1.5
1.5
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
12
18
6.71
7.61
1.1
1.1
mmol/l
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
669
5598
1.36
7.58
6.3
4.8
estimate
0.0
0.0
0.00
148
1057
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
93
507
1.89
7.41
2.5
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
673
5664
1.35
7.22
4.7
3.5
estimate
0.0
0.0
0.80
134
999
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
48
205
2.39
7.18
1.1
1.1
iu/ml
255.2
54.8
—
8
35
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
10
13
7.74
7.12
3.6
6.8
ug/min
58.2
62.2
—
10
13
(3027273) Bicarbonate [Moles/volume] in Venous blood
110
640
1.78
7.12
6.8
3.2
mmol/l
23.7
25.1
3.57
104
616
(3047181) Lactate [Moles/volume] in Blood
78
407
1.97
7.08
9.7
6.2
mmol/l
1.6
1.4
1.44
68
346
(40768443) Skin Pathology biopsy report
88
482
1.88
6.92
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
44
4.13
6.82
2.3
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
85
464
1.88
6.76
2.0
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
16
36
4.48
6.71
1.2
1.7
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
15
32
4.73
6.69
1.8
1.3
ug/l
1.3
28.6
—
7
15
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
222
2.25
6.44
1.6
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
11
18
6.15
6.43
1.1
1.4
%
86.5
97.2
0.37
11
18
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
50
231
2.21
6.28
1.1
1.1
u/ml
1.2
7.0
—
5
13
(4198724)
14
30
4.70
6.22
16.1
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
24
77
3.15
6.18
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
55
266
2.11
6.16
3.8
2.2
g/l
113.4
130.9
4.21
46
201
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
103
616
1.72
6.08
2.4
2.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
38
158
2.44
6.06
1.1
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
94
2.91
6.06
1.7
1.3
g/l
11.5
6.5
2.01
16
67
(3019225) pH of Specimen
177
1213
1.52
6.01
7.3
4.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
176
1206
1.52
5.98
2.9
2.3
ug/g
140.4
161.1
0.46
145
973
(4062490)
27
95
2.88
5.96
1.7
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
52
250
2.12
5.93
4.2
2.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
16
40
4.03
5.90
2.2
2.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1190
12579
0.70
5.90
52.0
17.4
umol/l
88.9
81.7
6.31
1190
12574
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
59
3.42
5.87
2.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
59
3.42
5.87
2.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
59
3.42
5.87
2.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
59
3.42
5.87
2.3
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
33
131
2.55
5.81
1.4
2.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
594
0.36
5.77
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
76
3.06
5.66
1.5
2.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
37
4.09
5.63
1.1
1.4
—
—
—
0
0
(3000492) Spirometry study
161
1098
1.52
5.59
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
99
2.76
5.54
1.6
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
94
2.80
5.48
1.8
1.3
g/l
3.1
2.7
0.31
16
67
(3024139) IgG subclass 3 [Mass/volume] in Serum
26
94
2.80
5.48
1.8
1.3
g/l
0.6
0.4
1.19
16
64
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
67
3.17
5.47
2.2
3.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
145
971
1.55
5.47
5.0
3.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
106
2.67
5.42
1.8
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
42
193
2.21
5.38
4.9
3.6
—
—
—
0
0
(44790048)
35
149
2.38
5.34
2.2
1.6
—
—
—
0
0
(44790049)
35
149
2.38
5.34
2.2
1.6
—
—
—
0
0
(44806118)
35
149
2.38
5.34
2.2
1.6
—
—
—
0
0
(44790047)
35
149
2.38
5.34
2.2
1.6
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
5
0
+∞
5.21
15.0
0.0
ug/l
9.1
—
—
5
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
44
3.67
5.21
2.5
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
44
3.67
5.21
2.5
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
54
279
1.97
5.12
1.2
1.2
u/ml
5.0
4.2
—
6
28
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
70
3.03
5.11
1.8
3.0
%
43.2
36.8
—
7
23
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
50
3.43
5.03
1.2
2.0
umol/l
63.1
98.5
—
7
28
(40768446) Kidney Pathology biopsy report
17
50
3.43
5.03
1.4
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
35
154
2.30
4.98
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
54
283
1.94
4.92
1.2
1.1
u/ml
3.0
3.5
—
6
38
(3039443) Prostate specific Ag panel - Serum or Plasma
10
362
0.27
4.68
1.3
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
199
2.09
4.62
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
284
2222
1.35
4.60
3.8
3.1
mmol/l
2.5
2.5
2.49
239
1950
(3020876) Protein [Mass/time] in 24 hour Urine
27
110
2.48
4.56
1.5
1.9
—
1.2
—
0
5
(4212803)
8
8
10.05
4.52
1.0
1.1
—
—
—
0
0
(4268621)
25
99
2.55
4.47
2.8
2.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
15
44
3.43
4.47
1.2
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
76
2.79
4.46
1.5
2.8
%
14.4
11.2
0.35
12
37
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
130
2.34
4.45
2.3
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
32
144
2.25
4.36
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1196
12534
0.74
4.31
35.0
10.5
u/l
34.5
27.4
22.89
1179
12077
(3016750) Collection duration of Urine
21
78
2.72
4.26
2.0
2.2
min
478.6
489.7
0.15
16
49
(3034426) Prothrombin time (PT)
12
31
3.89
4.26
1.6
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
26
108
2.43
4.23
6.6
2.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
127
2.31
4.21
1.2
1.3
mosm/kgh2o
286.2
281.1
0.36
20
92
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
39
193
2.05
4.21
1.6
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
13
36
3.63
4.21
1.1
1.1
—
14.2
—
0
5
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
24
98
2.47
4.06
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
170
2.08
3.98
1.5
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
47
256
1.86
3.88
1.3
1.4
u/l
12.4
7.8
0.72
31
199
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
78
1199
0.63
3.86
1.5
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
16
54
2.98
3.85
2.9
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
15
395
0.37
3.82
1.1
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
146
2.15
3.82
2.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
108
2.34
3.77
2.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
108
2.34
3.77
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
108
2.34
3.77
2.1
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
311
1.76
3.74
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
19
73
2.62
3.64
4.1
3.1
ph
7.4
7.4
0.80
11
24
(3014765) Yersinia sp identified in Stool by Organism specific culture
54
314
1.75
3.63
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
40
3.27
3.63
1.1
1.0
miu/ml
1801.6
1398.8
0.72
13
40
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
184
1.98
3.60
1.5
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
9
7.81
3.56
1.1
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
54
317
1.73
3.52
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
393
0.40
3.50
1.1
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
83
2.43
3.31
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
102
2.28
3.30
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
107
753
1.45
3.26
2.9
3.3
e9/l
3.6
4.2
1.15
75
566
(3029937) Albumin [Presence] in Urine by Test strip
363
3062
1.25
3.22
5.4
3.8
estimate
0.0
0.0
0.69
130
990
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
36
192
1.90
3.22
1.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
33
3.35
3.19
1.0
2.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
44
2.97
3.14
1.2
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
17
67
2.56
3.13
2.4
3.0
mmol/l
8.4
9.5
0.42
11
52
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
29
3.47
3.05
1.0
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
62
2.60
3.05
1.1
1.7
nmol/l
0.3
0.2
0.30
16
49
(3023419) Bacteria identified in Sputum by Culture
34
182
1.89
3.02
4.9
2.6
—
—
—
0
0
(1002224) Polysomnography panel
21
434
0.48
2.99
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
40
3.02
2.97
1.3
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
154
1174
1.35
2.96
2.3
2.4
ug/l
5.6
7.7
0.96
132
1053
(40761535) Cells panel - Urine sediment
136
1017
1.37
2.96
3.6
3.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
351
1.62
2.91
1.6
1.6
iu/ml
1.0
19.6
0.47
13
62
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
59
376
1.59
2.87
2.6
3.7
u/ml
162.2
80.1
1.17
59
361
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
42
246
1.73
2.81
2.1
3.1
nmol/l
0.8
0.8
0.10
20
191
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
18
4.46
2.79
1.7
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1060
11143
0.82
2.79
10.6
6.1
mmol/mol
42.9
40.4
7.48
1004
10278
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
59
2.56
2.79
1.1
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
23
3.93
2.77
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
14
5.02
2.73
1.4
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
60
2.52
2.70
1.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
140
1.95
2.66
6.9
4.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
140
1.95
2.66
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
16
67
2.40
2.63
3.6
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
68
2.37
2.56
2.7
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
26
3.48
2.48
1.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
26
3.48
2.48
2.2
2.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
82
2.21
2.48
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
82
2.21
2.48
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
89
2.15
2.45
1.6
2.2
ug/min
147.0
159.6
—
5
20
(3020961) Endomysium IgA Ab [Titer] in Serum
68
467
1.48
2.41
1.1
1.1
titre
—
211.6
—
0
10
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
8
6.27
2.37
1.2
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
8
6.27
2.37
5.0
4.6
—
—
—
0
0
(3000012) Reticulocyte production index
14
58
2.43
2.37
2.0
1.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
18
84
2.16
2.35
1.3
1.4
u/l
20.6
31.4
0.70
12
67
(3011288) Drugs identified in Urine by Screen method
28
154
1.83
2.35
9.0
2.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
53
2.47
2.28
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
18
3.90
2.25
1.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
18
3.90
2.25
9.3
5.2
mmol/l
6.2
5.8
—
7
18
(4094501)
20
378
0.52
2.25
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
9
5.57
2.21
1.0
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
42
2.63
2.18
1.4
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
67
2.25
2.18
3.3
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
19
3.70
2.15
1.9
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
74
2.18
2.15
1.6
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
74
2.18
2.15
1.6
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
25
3.21
2.09
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
25
3.21
2.09
2.3
5.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
89
2.04
2.06
1.6
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
15
4.01
2.04
1.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
15
4.01
2.04
2.0
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
63
2.23
2.01
2.0
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1173
12122
0.83
1.99
43.1
14.0
—
—
—
0
0
(4146454)
28
164
1.72
1.95
3.3
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
64
2.20
1.94
1.3
1.1
nmol/l
129.9
144.1
0.41
14
64
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
49
710
0.68
1.93
1.2
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
16
3.76
1.93
1.8
2.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
33
2.74
1.93
2.8
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
30
180
1.68
1.92
8.4
1.7
—
—
—
0
0
(3013512) EKG study
411
3674
1.17
1.87
5.4
3.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
34
2.66
1.86
1.8
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
100
1.91
1.86
1.5
2.1
u/field
2.0
1.6
0.15
12
41
(3044941) Cell count panel - Synovial fluid
32
198
1.63
1.84
1.6
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
23
130
1.78
1.82
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1201
12364
0.84
1.81
54.4
17.5
mmol/l
4.0
4.0
1.36
1181
12046
(3016879) Cocaine [Presence] in Urine
35
223
1.58
1.80
7.3
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
138
0.36
1.74
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
234
1.55
1.71
7.2
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
48
2.30
1.70
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
36
236
1.54
1.66
7.2
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
25
2.81
1.65
1.9
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
130
0.38
1.63
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1005
10460
0.87
1.60
4.7
4.3
mu/l
2.4
2.1
1.18
920
9455
(3017704) Immunofixation for Urine
15
77
1.96
1.59
1.1
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
14
70
2.01
1.59
3.2
2.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
61
448
1.38
1.59
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
232
1.52
1.55
7.5
1.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
12
57
2.11
1.55
1.7
2.8
ml
2085.8
1788.1
0.76
12
50
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
64
2.04
1.54
2.8
2.6
u/ml
1269.5
1073.1
0.19
13
64
(40757373) Influenza virus identified in Isolate
7
27
2.60
1.51
1.3
1.9
—
—
—
0
0
(4010399)
107
860
1.26
1.50
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1201
12325
0.85
1.48
54.0
17.3
mmol/l
138.0
139.7
58.13
1181
12028
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
171
1.59
1.46
4.6
2.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
35
236
1.49
1.45
1.3
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1078
11138
0.88
1.42
40.5
13.8
ml/min/173m2
77.4
78.6
0.78
970
9205
(3002385) Erythrocyte distribution width [Ratio]
1002
9623
1.13
1.42
57.0
17.9
%
15.4
13.7
113.64
994
9398
(3035320) C reactive protein [Mass/volume] in Body fluid
13
67
1.95
1.38
3.5
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
45
325
1.40
1.33
1.6
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
44
317
1.40
1.32
5.6
4.8
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
24
2.51
1.30
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
204
1778
1.17
1.29
1.2
1.2
iu/ml
78.6
32.3
1.06
62
564
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
55
2.01
1.27
3.0
4.2
—
—
—
0
0
(44806420)
9
44
2.05
1.27
2.8
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1196
11649
1.15
1.26
44.9
14.7
mg/l
21.3
26.1
8.96
1142
9285
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
117
0.43
1.25
1.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
36
2.23
1.24
1.9
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
22
139
1.59
1.23
1.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
63
1.91
1.23
1.3
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
31
213
1.47
1.21
1.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
465
4311
1.12
1.16
5.3
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
34
473
0.71
1.16
1.1
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
39
2.06
1.15
4.8
6.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
20
2.50
1.15
1.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
60
1.84
1.03
2.4
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
34
2.06
1.03
5.9
2.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
47
1.92
1.02
1.1
1.1
iu/ml
344.2
218.2
—
9
47
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
15
237
0.63
0.99
1.5
1.9
iu/l
2.7
4.8
—
5
78
(3017446) Testosterone [Moles/volume] in Serum or Plasma
100
1183
0.83
0.99
1.9
2.2
nmol/l
13.4
13.2
0.06
83
1042
(3045424) Erythrocytes [Presence] in Urine
28
198
1.42
0.98
1.3
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
36
1.95
0.97
4.4
6.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
77
1.69
0.95
1.6
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
272
2477
1.12
0.94
5.8
3.8
kg/l
1.0
1.0
0.28
59
352
(4034850)
29
395
0.73
0.92
21.8
9.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
324
0.71
0.89
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
40
308
1.31
0.86
1.6
1.7
e6/l
18448.5
15208.5
0.24
25
226
(3051593) INR in Capillary blood by Coagulation assay
10
58
1.73
0.79
3.9
13.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
90
1.56
0.78
1.2
1.1
titre
—
—
—
0
0
(3044889) 12 lead EKG panel
831
8587
0.92
0.77
4.7
4.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
123
1.47
0.77
1.1
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
319
2963
1.10
0.77
4.4
3.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
34
1.77
0.76
36.0
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
236
1.32
0.74
1.5
1.4
iu/l
31.1
24.9
0.40
24
188
(3045414) Leukocytes [Presence] in Urine
63
526
1.21
0.72
1.7
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
42
1.67
0.68
3.6
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
42
1.67
0.68
3.6
2.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
92
0.54
0.67
1.2
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
70
1.58
0.65
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
70
1.58
0.65
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
189
0.69
0.64
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
79
1.52
0.62
3.6
2.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
20
0.00
0.60
0.0
2.2
—
2.9
—
0
6
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
573
0.83
0.59
1.6
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
174
0.69
0.59
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
54
637
0.84
0.58
1.6
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
951
9727
0.94
0.58
58.6
19.2
g/l
331.5
333.1
4.71
940
9658
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
13.7
—
0.4
—
0
23
(3004451) EKG impression Narrative
11
73
1.51
0.56
1.5
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
206
0.73
0.55
1.6
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
37
1.62
0.55
3.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
17
125
1.36
0.53
1.5
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
63
1.43
0.52
1.1
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
83
1.45
0.52
1.3
1.3
u/ml
0.2
0.2
—
7
44
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
821
8418
0.94
0.51
3.7
3.6
pmol/l
14.6
14.9
2.94
730
7561
(3013139) Helicobacter pylori Ag [Presence] in Stool
82
727
1.14
0.50
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
76
1.45
0.48
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1067
10496
1.06
0.46
50.0
16.1
%
35.2
39.9
52.44
753
7241
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
31
1.61
0.43
1.0
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
122
1.31
0.42
1.4
1.4
e6/l
358130.8
147898.9
—
10
85
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
88
972
0.90
0.41
1.3
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
41.6
—
0
16
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
161
0.74
0.41
1.0
1.2
u/ml
0.1
2.4
—
7
75
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
150
1.27
0.40
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
618
6351
0.95
0.39
2.9
2.5
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
19
0.00
0.39
0.0
1.6
—
7.4
—
0
9
(40765089) Chromosome analysis panel - Blood by G-banded
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
70
628
1.12
0.38
4.5
3.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
152
1418
1.08
0.38
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
72
1.39
0.37
1.5
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
337
1.16
0.36
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
78
0.64
0.35
1.0
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
100
1.30
0.33
1.2
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
4.3
2.2
umol/l
65.2
52.8
—
6
36
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
183
1.21
0.32
2.1
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
26
303
0.86
0.29
2.0
1.9
pmol/l
191.7
213.4
0.72
26
281
(3016018) Differential panel - Cerebral spinal fluid
10
130
0.77
0.29
1.1
1.8
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.4
1.6
ug/l
13.9
7.6
—
7
50
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
32
279
1.15
0.28
1.2
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
32
279
1.15
0.28
1.5
1.2
—
—
—
0
0
(44813793)
8
66
1.21
0.26
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
613
0.91
0.26
1.1
1.2
iu/ml
73.5
149.3
0.75
18
226
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
348
0.89
0.23
1.8
1.7
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
92
0.76
0.22
1.6
1.3
mmol/l
2.3
2.0
—
7
87
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
167
0.84
0.21
1.0
1.1
—
14.3
—
0
6
(3024316) Viscosity of Plasma
0
11
0.00
0.21
0.0
1.5
—
1.5
—
0
5
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
44.6
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
13
0.00
0.21
0.0
6.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
13
0.00
0.21
0.0
3.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
330
3213
1.04
0.21
2.1
1.7
mmol/l
1.5
1.4
0.55
293
2653
(3049717) Cytology report of Urine Cyto stain
54
581
0.93
0.19
2.2
2.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
24
269
0.89
0.18
1.3
1.7
e6/l
4.9
869.7
1.13
17
218
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
24
269
0.89
0.18
1.2
1.7
e6/l
13.9
38.7
0.51
16
211
(1617658) Protocol used for examination of sentinel lymph nodes
5
67
0.75
0.17
1.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
120
0.83
0.16
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
54
576
0.94
0.16
2.7
3.5
pmol/l
3.8
4.5
3.19
45
497
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
8
72
1.11
0.16
1.9
1.3
u/l
21.6
9.7
—
8
60
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
149
1.14
0.15
1.1
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
80
0.75
0.15
1.5
4.1
u/ml
18.7
55.4
—
6
80
(3022621) pH of Urine by Test strip
80
763
1.05
0.14
3.2
2.8
—
—
—
0
0
(4024509)
9
107
0.84
0.13
1.9
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
147
0.88
0.11
1.3
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
159
1550
1.03
0.11
16.4
6.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
146
0.89
0.10
1.4
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
156
1525
1.03
0.09
4.5
4.7
%
32.7
32.1
0.25
126
1011
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
48
1.04
0.09
1.0
1.1
—
69.8
—
0
8
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
55
1.09
0.09
1.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
61
0.82
0.08
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
245
0.94
0.07
1.2
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
157
1.08
0.07
1.8
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
27
283
0.95
0.05
2.1
2.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
169
1.07
0.05
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
50
490
1.02
0.02
1.7
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
170
1706
1.00
0.00
1.2
1.2
u/ml
14.9
12.5
0.16
46
637
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
286
1.01
0.00
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
132
0.98
0.00
1.2
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
141
0.99
0.00
1.4
1.5
%
80.9
65.0
—
8
88
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
127
1.02
0.00
1.2
1.3
nmol/l
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
143
0.98
0.00
1.1
1.3
nmol/l
0.8
0.7
0.34
14
136
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
14
143
0.98
0.00
1.1
1.3
nmol/l
0.2
0.4
—
5
14
(3005570) Glucose [Moles/volume] in Urine
12
125
0.96
0.00
1.3
2.0
—
—
—
0
0
(4211845)
5
55
0.91
0.00
4.0
2.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
230
1.00
0.00
2.1
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
128.6
—
0
5
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.4
—
0
5
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
569.7
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
8.0
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
49
1.02
0.00
1.4
1.2
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
80
1.00
0.00
3.1
1.6
—
75.7
—
0
7
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
203.0
—
0
6
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
0.0
—
0
7
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
169.4
—
0
5
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
3.4
—
0
8
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
8.3
—
0
9
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
2.5
—
0
7
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_VARICVEOES and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_VARICVEOES | 8.066 [6.74, 9.65] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 1624 out of 2914 females with I9_VARICVEOES died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_VARICVEOES | 9.18 [7.92, 10.63] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 3955 out of 6272 males with I9_VARICVEOES died.
Mortality risk
Mortality risk for people of age
years, who have I9_VARICVEOES.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.878% | 1.631% |
| 5 | 4.186% | 9.69% |
| 10 | 10.017% | 21.728% |
| 15 | 18.217% | 37.731% |
| 20 | 30.053% | 54.018% |
Relationships between endpoints
↥Index endpoint: I9_VARICVEOES – Oesophageal varices
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data